Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2009;53:150-157
Published online before print December 15, 2008, doi: 10.1161/HYPERTENSIONAHA.108.117622
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
53/2/150    most recent
HYPERTENSIONAHA.108.117622v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schumacher, W.
Right arrow Articles by Ben-Shlomo, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schumacher, W.
Right arrow Articles by Ben-Shlomo, Y.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*SNP
*UniGene
*Substance via MeSH
Related Collections
Right arrow Pathophysiology
Right arrow Risk Factors
Right arrow Epidemiology
Right arrow Genetics of cardiovascular disease
Right arrow Other Research

(Hypertension. 2009;53:150.)
© 2009 American Heart Association, Inc.


Original Articles

Association Between C-Reactive Protein Genotype, Circulating Levels, and Aortic Pulse Wave Velocity

Wiebke Schumacher; John Cockcroft; Nicholas J. Timpson; Carmel M. McEniery; John Gallacher; Ann Rumley; Gordon Lowe; George Davey Smith; Ian B. Wilkinson; Yoav Ben-Shlomo

From the MRC CAiTE Centre (N.J.T., G.D.S., Y.B.-S.), Department of Social Medicine (W.S., Y.B.-S.), University of Bristol; Wales Heart Research Institute (J.C.), University Hospital Heath Park, Cardiff; Clinical Pharmacology Unit (C.M., I.W.), University of Cambridge, Addenbrooke’s Hospital; Department of Epidemiology (J.G.), Statistics and Public Health, Cardiff University Wales College of Medicine; and University Department of Medicine (A.R., G.L.), Royal Infirmary, Glasgow, United Kingdom.

Correspondence to Y. Ben-Shlomo, Department of Social Medicine, University of Bristol, Canynge Hall, Whiteladies Road, Bristol, BS8 2PR, UK. E-mail y.ben-shlomo{at}bristol.ac.uk

Circulating C-reactive protein (CRP) level is associated with cardiovascular disease. Whether this relationship is causal has been subject of debate, especially as a potential therapeutic target. Previous studies have demonstrated an association between circulating CRP levels and arterial pulse wave velocity, an accepted measure of arterial stiffness. We investigated the association between circulating CRP levels, CRP genotype, and aortic pulse wave velocity by examining data on 790 healthy male participants of the Caerphilly study. Circulating CRP levels were associated with aortic pulse wave velocity after adjustment for cardiovascular risk factors and other potential confounders (P=0.001). Three single nucleotide polymorphisms in the CRP gene (rs1130864, rs1800947, and rs1205) were associated with differences in circulating CRP levels (ratio of geometric means: 1.12, 95% CI 1.03 to 1.21, P=0.005; 0.76, 95% CI 0.66 to 0.87, P<0.001; 0.88, 95% CI 0.81 to 0.95, P=0.001, respectively). However, there was no relationship between any of the genotypes and aortic pulse wave velocity (regression coefficient for C:G/G:G versus C:C genotypes for single nucleotide polymorphism rs1800947 β=0.005; 95% CI, –0.57 to 0.58; P=0.99). These results suggest that although circulating CRP levels are associated with aortic pulse wave velocity, CRP does not have a causal role in the development of arterial stiffness. CRP may simply act as a marker of vascular damage (ie, reverse causality), or the association reflects residual confounding. Further studies are needed to confirm these findings, particularly in view of the central role CRP has played in cardiovascular disease so far.


Key Words: C-reactive protein • vascular resistance • atherosclerosis • risk factors • genotype




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
E. Mousseaux
Obesity and cardiovascular disease: how can cardiac magnetic resonance help?
J. Am. Coll. Cardiol., August 18, 2009; 54(8): 727 - 729.
[Full Text] [PDF]


Home page
HypertensionHome page
C. Vlachopoulos, D. Terentes-Printzios, I. Dima, K. Aznaouridis, and C. Stefanadis
Polymorphisms of Inflammatory Markers/Mediators and Arterial Stiffness
Hypertension, June 1, 2009; 53(6): e39 - e39.
[Full Text] [PDF]